ARCHIVES

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

This article is from The Cancer Letter archive.

Vol. 14 No. 43 | November 4, 1988

Download PDF Visit The Full Archive

Related Articles

Klausner Unveils New NCI Structure, Aims To Change Institute’s “Ethos”

August 11, 1995

In Brief: New Spending Plan Funds NIH At FY95 Level; Continuing Resolution Expires Dec. 15

November 24, 1995

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

July 27, 2001

Radiation Improves Survival In Advanced Prostate Cancer

June 25, 2010

Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds

June 29, 2007